Clinical Trials Browser

Unknown × Leukemia, Myeloid, Acute × Etoposide × Clear all

Leukemia, Myeloid, Acute

NCT05665114 2023-01-03

Natural Killer(NK) Cell Therapy in r/r AML

Phase 1 Unknown

18 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00002658 2013-12-19

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

Phase 3 Unknown

2,000 enrolled

Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT00002688 2013-12-19

Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 2 Unknown

25 enrolled

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT00006045 2013-11-06

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00002549 2009-12-23

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia

Phase 3 Unknown

1,520 enrolled

Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00004128 2009-12-23

Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Phase 3 Unknown

2,000 enrolled

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00199147 2005-10-26

Efficacy of G-CSF-Priming in Elderly AML Patients

Phase 4 Unknown

250 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Clinical Trials

Natural Killer (NK) Cell Therapy Targeting CD33 in Acute Myeloid Leukemia

Natural Killer(NK) Cell Therapy in r/r AML

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia

Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Efficacy of G-CSF-Priming in Elderly AML Patients